Alimera Sciences reported $-5245000 in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Alimera Sciences ALIM:US USD -5245000 2.15M
Insmed INSM:US USD -130773000 35.63M
Novartis NOVN:VX USD 4.06B 72M
Ophthotech OPHT:US USD -42351000 6.91M
Regeneron Pharmaceuticals REGN:US USD 1.45B 140.6M
Roche Holding ROG:VX 12.11B 2.43B